Have your own idea? Try our Stock Screener
The Medical Equipment industry is up 3.6% in the last week, with Shandong Weigao Group Medical Polymer up 8.0%. During this same period, the OrbusNeich Medical Group Holdings underperformed, falling 6.8%. In the past year, the industry is down 14%. Earnings are forecast to grow by 41% annually.
Has the Hong Kong Medical Equipment Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Tue, 21 Jan 2025 | HK$133.6b | HK$57.8b | HK$1.2b | 18.4x | 114.2x | 2.3x |
Thu, 19 Dec 2024 | HK$136.5b | HK$57.9b | HK$1.2b | 17x | 115.3x | 2.4x |
Sat, 16 Nov 2024 | HK$132.5b | HK$58.3b | HK$1.2b | 16.2x | 109.2x | 2.3x |
Mon, 14 Oct 2024 | HK$144.7b | HK$59.3b | HK$1.4b | 13.8x | 105.2x | 2.4x |
Wed, 11 Sep 2024 | HK$115.2b | HK$59.0b | HK$1.3b | 12.4x | 90.1x | 2x |
Fri, 09 Aug 2024 | HK$120.0b | HK$54.5b | -HK$1,017,711,749.73 | 12.2x | -117.9x | 2.2x |
Sun, 07 Jul 2024 | HK$124.1b | HK$53.9b | -HK$1,099,407,474.63 | 12.6x | -112.8x | 2.3x |
Tue, 04 Jun 2024 | HK$137.7b | HK$54.1b | -HK$1,095,824,529.44 | 13.1x | -125.6x | 2.5x |
Thu, 02 May 2024 | HK$154.8b | HK$54.1b | -HK$1,093,945,754.74 | 15.7x | -141.5x | 2.9x |
Sat, 30 Mar 2024 | HK$147.3b | HK$54.1b | -HK$1,426,745,114.47 | 13.1x | -103.3x | 2.7x |
Mon, 26 Feb 2024 | HK$160.0b | HK$52.7b | -HK$1,116,753,596.51 | 12.7x | -143.3x | 3x |
Wed, 24 Jan 2024 | HK$163.1b | HK$53.6b | -HK$2,350,430,966.00 | 12.4x | -69.4x | 3x |
Fri, 22 Dec 2023 | HK$195.6b | HK$53.6b | -HK$2,343,458,731.00 | 14.7x | -83.5x | 3.6x |
Sun, 19 Nov 2023 | HK$217.7b | HK$53.2b | -HK$2,338,413,317.00 | 18.1x | -93.1x | 4.1x |
Tue, 17 Oct 2023 | HK$206.8b | HK$52.8b | -HK$2,343,493,488.00 | 20.6x | -88.2x | 3.9x |
Thu, 14 Sep 2023 | HK$212.3b | HK$53.0b | -HK$2,344,517,431.00 | 16.5x | -90.6x | 4x |
Sat, 12 Aug 2023 | HK$226.8b | HK$50.9b | -HK$3,933,660,878.00 | 18.5x | -57.7x | 4.5x |
Mon, 10 Jul 2023 | HK$241.4b | HK$51.0b | -HK$3,940,156,516.00 | 19.1x | -61.3x | 4.7x |
Wed, 07 Jun 2023 | HK$250.6b | HK$51.6b | -HK$3,960,837,433.00 | 19.8x | -63.3x | 4.9x |
Fri, 05 May 2023 | HK$292.5b | HK$52.7b | -HK$3,990,208,292.00 | 22.3x | -73.3x | 5.6x |
Sun, 02 Apr 2023 | HK$299.2b | HK$53.2b | -HK$3,595,314,499.00 | 24.3x | -83.2x | 5.6x |
Tue, 28 Feb 2023 | HK$301.4b | HK$53.9b | -HK$2,785,917,985.00 | 24.4x | -108.2x | 5.6x |
Thu, 26 Jan 2023 | HK$314.0b | HK$54.7b | -HK$2,743,741,181.00 | 23.9x | -114.5x | 5.7x |
Sat, 24 Dec 2022 | HK$274.6b | HK$53.4b | -HK$2,661,828,473.00 | 22.1x | -103.2x | 5.1x |
Mon, 21 Nov 2022 | HK$255.6b | HK$51.8b | -HK$2,701,505,689.00 | 21.8x | -94.6x | 4.9x |
Wed, 19 Oct 2022 | HK$241.6b | HK$51.4b | -HK$2,775,672,367.00 | 20.2x | -87.1x | 4.7x |
Fri, 16 Sep 2022 | HK$232.5b | HK$52.4b | -HK$2,576,301,740.00 | 17.1x | -90.2x | 4.4x |
Sun, 14 Aug 2022 | HK$251.3b | HK$51.1b | -HK$529,757,683.00 | 16.4x | -474.4x | 4.9x |
Tue, 12 Jul 2022 | HK$263.7b | HK$51.3b | -HK$607,000,719.00 | 16.5x | -434.5x | 5.1x |
Thu, 09 Jun 2022 | HK$213.7b | HK$51.5b | -HK$590,765,110.00 | 14.4x | -361.7x | 4.1x |
Sat, 07 May 2022 | HK$191.5b | HK$51.6b | -HK$591,491,330.00 | 14.7x | -323.8x | 3.7x |
Mon, 04 Apr 2022 | HK$221.5b | HK$53.1b | -HK$423,182,623.00 | 15.7x | -523.5x | 4.2x |
Wed, 02 Mar 2022 | HK$282.6b | HK$47.8b | HK$2.3b | 18.9x | 124.2x | 5.9x |
Fri, 28 Jan 2022 | HK$275.6b | HK$47.5b | HK$2.3b | 19x | 121.3x | 5.8x |
121.3x
Which industries have driven the changes within the Hong Kong Healthcare industry?
HK Market | 3.38% | |
Healthcare | 2.49% | |
Medical Equipment | 3.58% | |
Medical Supplies | 3.68% | |
Medical Equipment | 3.51% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
1066 Shandong Weigao Group Medical Polymer | HK$4.48 | 8.0% +HK$1.5b | -17.8% | PE10.1x | |
2252 Shanghai MicroPort MedBot (Group) | HK$9.81 | 12.6% +HK$1.1b | -26.5% | PS59.4x | |
853 MicroPort Scientific | HK$5.58 | 6.7% +HK$646.4m | -6.1% | PS1.3x | |
2172 MicroPort NeuroScientific | HK$8.65 | 4.8% +HK$230.9m | -4.5% | PE20.9x | |
1302 LifeTech Scientific | HK$1.36 | 3.0% +HK$185.2m | -27.7% | PE23.8x |